Submit Deal

PAHR THERAPEUTICS INC

HQ - Osaka

Summary

Pahr Therapeutics is a clinical stage company focused on developing novel mechanisms for the treatment of pulmonary arterial hypertension.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 10 M

Avg. Deal Size£ 10 M

Market Context

Senior Management

Sort

Target: PAHR THERAPEUTICS INC

Bidder: RA CAPITAL MANAGEMENT

5 Service Providers

6 Dealmakers

£ 10 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy